Deceived by Ultrasound: An Unexpected Discovery of Aggressive Peritoneal Malignancy Disguised as a Benign Gynecologic Complaint

Lev Tohar^1, , Gerk Alexis¹, Lentz Kristen¹ and Bachman Ira¹

¹Obstetrics and Gynecology, Mount Sinai South Nassau, Oceanside, NY

Cite this paper:
Lev Tohar, Gerk Alexis, Lentz Kristen and Bachman Ira. Deceived by Ultrasound: An Unexpected Discovery of Aggressive Peritoneal Malignancy Disguised as a Benign Gynecologic Complaint. American Journal of Medical Case Reports. 2025; 13(3):19-21. doi: 10.12691/ajmcr-13-3-3

Abstract

Commonly diagnosed at an advanced stage, peritoneal mesothelioma is a rare and highly aggressive malignancy. This case demonstrates an atypical presentation of sarcomatoid mesothelioma, identified by gynecologists due to concern for hemorrhagic cyst.

Keywords:
sarcomatoid mesothelioma hemorrhagic cyst oncology

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Seshadri, Anupamaa, and Erika Rangel. "Peritoneal Cavity." Current Diagnosis & Treatment: Surgery, 15e Ed. Gerard M. Doherty. McGraw Hill LLC, 2020, https://accessmedicine-mhmedical-com.neomed.idm.oclc.org/ content.aspx? bookid=2859 & sectionid=242157732.
[2]	Fels Elliott DR, Jones KD. Diagnosis of Mesothelioma. Surg Pathol Clin. 2020 Mar; 13(1): 73-89.
[3]	Steadman JA, Grotz TE. Principles of Surgical Management of Peritoneal Mesothelioma. J Natl Compr Canc Netw. 2023 Sep; 21(9): 981-986.
[4]	Verma V, Sleightholm RL, Rusthoven CG, Koshy M, Sher DJ, Grover S, Simone CB 2nd. Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival. Ann Surg Oncol. 2018 Jul; 25(7): 2018-2026.
[5]	Calthorpe L, Romero-Hernandez F, Miller P, Conroy PC, Hirose K, Kim A, Kirkwood K, Nakakura E, Corvera C, Maker AV, Alseidi A, Adam MA. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States. Cancers (Basel). 2022 Dec 30; 15(1): 229.
[6]	Kindler HL. Peritoneal mesothelioma: the site of origin matters. Am Soc Clin Oncol Educ Book. 2013:182-8.
[7]	Notue YA, Mbessoh UI, Nganwa G, Pambe JN, Mefire AC, Moifo B, Sando Z. Sarcomatoid malignant peritoneal mesothelioma presenting as a localized mesenteric tumor with no previous asbestos exposure. J Surg Case Rep. 2020 Oct 28; 2020(10): rjaa419.
[8]	Chun CP, Song LX, Zhang HP, Guo DD, Xu GX, Li Y, Xin X, Cao J, Li F. Malignant peritoneal mesothelioma. Am J Med Sci. 2023 Jan; 365(1):99-103.
[9]	Zhang CH, Yu JW, Luo M. Multicystic peritoneal mesothelioma: A short review. Curr Probl Cancer. 2017 Sep-Oct; 41(5): 340-348.
[10]	Noiret B, Renaud F, Piessen G, Eveno C. Multicystic peritoneal mesothelioma: a systematic review of the literature. Pleura Peritoneum. 2019 Sep 25; 4(3): 20190024.
[11]	Bravo R, Jafari MD, Pigazzi A. The Utility of Diagnostic Laparoscopy in Patients Being Evaluated for Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy. Am J Clin Oncol. 2018 Dec; 41(12): 1231-1234.
[12]	Valle M, Federici O, Garofalo A. Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment. Surg Oncol Clin N Am. 2012 Oct; 21(4): 515-31.